Literature DB >> 26180081

Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions.

Sameer Agnihotri1, Gelareh Zadeh1.   

Abstract

A defining hallmark of glioblastoma is altered tumor metabolism. The metabolic shift towards aerobic glycolysis with reprogramming of mitochondrial oxidative phosphorylation, regardless of oxygen availability, is a phenomenon known as the Warburg effect. In addition to the Warburg effect, glioblastoma tumor cells also utilize the tricarboxylic acid cycle/oxidative phosphorylation in a different capacity than normal tissue. Altered metabolic enzymes and their metabolites are oncogenic and not simply a product of tumor proliferation. Here we highlight the advantages of why tumor cells, including glioblastoma cells, require metabolic reprogramming and how tumor metabolism can converge on tumor epigenetics and unanswered questions in the field.
© The Author(s) 2015. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Warburg effect; epigenetics; metabolic reprogramming; molecular signaling

Mesh:

Year:  2015        PMID: 26180081      PMCID: PMC4724176          DOI: 10.1093/neuonc/nov125

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  113 in total

Review 1.  Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation.

Authors:  Mireille Bélanger; Igor Allaman; Pierre J Magistretti
Journal:  Cell Metab       Date:  2011-12-07       Impact factor: 27.287

Review 2.  Aerobic glycolysis: meeting the metabolic requirements of cell proliferation.

Authors:  Sophia Y Lunt; Matthew G Vander Heiden
Journal:  Annu Rev Cell Dev Biol       Date:  2011       Impact factor: 13.827

Review 3.  Heterogeneity maintenance in glioblastoma: a social network.

Authors:  Rudy Bonavia; Maria-del-Mar Inda; Webster K Cavenee; Frank B Furnari
Journal:  Cancer Res       Date:  2011-05-31       Impact factor: 12.701

4.  Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme.

Authors:  Amparo Wolf; Sameer Agnihotri; Diana Munoz; Abhijit Guha
Journal:  Neurobiol Dis       Date:  2011-06-25       Impact factor: 5.996

5.  Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses.

Authors:  Dimitrios Anastasiou; George Poulogiannis; John M Asara; Matthew B Boxer; Jian-kang Jiang; Min Shen; Gary Bellinger; Atsuo T Sasaki; Jason W Locasale; Douglas S Auld; Craig J Thomas; Matthew G Vander Heiden; Lewis C Cantley
Journal:  Science       Date:  2011-11-03       Impact factor: 47.728

6.  Metabolic state of glioma stem cells and nontumorigenic cells.

Authors:  Erina Vlashi; Chann Lagadec; Laurent Vergnes; Tomoo Matsutani; Kenta Masui; Maria Poulou; Ruxandra Popescu; Lorenza Della Donna; Patrick Evers; Carmen Dekmezian; Karen Reue; Heather Christofk; Paul S Mischel; Frank Pajonk
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-07       Impact factor: 11.205

Review 7.  Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.

Authors:  Sybille Mazurek
Journal:  Int J Biochem Cell Biol       Date:  2010-02-13       Impact factor: 5.085

8.  Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner.

Authors:  Sutapa Banerjee; Nikkilina R Crouse; Ryan J Emnett; Scott M Gianino; David H Gutmann
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-06       Impact factor: 11.205

9.  Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.

Authors:  Saskia E Rademakers; Jasper Lok; Albert J van der Kogel; Johan Bussink; Johannes H A M Kaanders
Journal:  BMC Cancer       Date:  2011-05-12       Impact factor: 4.430

Review 10.  Mouse models to interrogate the implications of the differentiation status in the ontogeny of gliomas.

Authors:  Diana Marcela Muñoz; Abhijit Guha
Journal:  Oncotarget       Date:  2011-08
View more
  87 in total

Review 1.  Role of AHR and HIF-1α in Glioblastoma Metabolism.

Authors:  Galina Gabriely; Michael A Wheeler; Maisa C Takenaka; Francisco J Quintana
Journal:  Trends Endocrinol Metab       Date:  2017-03-16       Impact factor: 12.015

Review 2.  Metabolic heterogeneity and adaptability in brain tumors.

Authors:  Christian E Badr; Daniel J Silver; Florian A Siebzehnrubl; Loic P Deleyrolle
Journal:  Cell Mol Life Sci       Date:  2020-06-06       Impact factor: 9.261

3.  Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells.

Authors:  Sameer Agnihotri; Sheila Mansouri; Kelly Burrell; Mira Li; Yasin Mamatjan; Jeff Liu; Romina Nejad; Sushil Kumar; Shahrzad Jalali; Sanjay K Singh; Alenoush Vartanian; Eric Xueyu Chen; Shirin Karimi; Olivia Singh; Severa Bunda; Alireza Mansouri; Kenneth D Aldape; Gelareh Zadeh
Journal:  Clin Cancer Res       Date:  2018-10-15       Impact factor: 12.531

4.  Evaluation of Glycolytic Response to Multiple Classes of Anti-glioblastoma Drugs by Noninvasive Measurement of Pyruvate Kinase M2 Using [18F]DASA-23.

Authors:  Corinne Beinat; Chirag B Patel; Yuanyang Xie; Sanjiv S Gambhir
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

5.  Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastoma.

Authors:  Jing Cui; Qi Zhang; Qi Song; Herui Wang; Pauline Dmitriev; Mitchell Y Sun; Xiaoyu Cao; Yang Wang; Liemei Guo; Iris H Indig; Jared S Rosenblum; Chunxia Ji; Dongqing Cao; Kaiyong Yang; Mark R Gilbert; Yu Yao; Zhengping Zhuang
Journal:  Neuro Oncol       Date:  2019-11-04       Impact factor: 12.300

6.  Cerebrovascular Angiogenic Reprogramming upon LRP1 Repression: Impact on Sphingosine-1-Phosphate-Mediated Signaling in Brain Endothelial Cell Chemotactism.

Authors:  Amélie Vézina; Cyndia Charfi; Alain Zgheib; Borhane Annabi
Journal:  Mol Neurobiol       Date:  2017-05-17       Impact factor: 5.590

Review 7.  Beyond Alkylating Agents for Gliomas: Quo Vadimus?

Authors:  Vinay K Puduvalli; Rekha Chaudhary; Samuel G McClugage; James Markert
Journal:  Am Soc Clin Oncol Educ Book       Date:  2017

8.  Multi-Channel 3D Deep Feature Learning for Survival Time Prediction of Brain Tumor Patients Using Multi-Modal Neuroimages.

Authors:  Dong Nie; Junfeng Lu; Han Zhang; Ehsan Adeli; Jun Wang; Zhengda Yu; LuYan Liu; Qian Wang; Jinsong Wu; Dinggang Shen
Journal:  Sci Rep       Date:  2019-01-31       Impact factor: 4.379

Review 9.  The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells.

Authors:  Catherine J Libby; Anh Nhat Tran; Sarah E Scott; Corinne Griguer; Anita B Hjelmeland
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-01-31       Impact factor: 10.680

Review 10.  Cancer metabolism as a central driving force of glioma pathogenesis.

Authors:  Kenta Masui; Webster K Cavenee; Paul S Mischel
Journal:  Brain Tumor Pathol       Date:  2016-06-13       Impact factor: 3.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.